Study of the Efficacy of Neurofeedback Training on Chemotherapy-Induced Neuropathy Receives 2018 FNAN Award
Retrieved on:
星期一, 五月 21, 2018
Estimates of this incidence of chemotherapy-induced peripheral neuropathy (CIPN) after treatment can range as high as 71% to 96%.
Key Points:
- Estimates of this incidence of chemotherapy-induced peripheral neuropathy (CIPN) after treatment can range as high as 71% to 96%.
- Each patient in the neurofeedback group received twenty sessions of training based on their own qEEG pattern.
- This study shows that neurofeedback can offer an alternative to pain medication which is well accepted by patients."
- FNAN awards its prize for the best neurofeedback article on an annual basis.